Non Proliferative Diabetic Retinopathy
8
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
25.0%
2 terminated out of 8 trials
50.0%
-36.6% vs benchmark
63%
5 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (8)
Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study)
Changes in Macular Thickness After Patterns Scan Laser
Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study
Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy